Physician profile
Veena Basava
NPI 1700195138
$3,915.63
in general payments reported to CMS, 2019-2025
22 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.93 · 2020: $282 · 2021: $1,774 · 2022: $471 · 2023: $279 · 2024: $544 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,543.34 | 2021-2022 | |
| Medtronic, INC. | $970.49 | 2021-2025 | Intellis Adaptivestim, Osteocool Rf Ablation System, Inceptiv |
| Abbott Laboratories | $412.55 | 2019-2025 | Proclaim, Eterna |
| Medtronic USA, INC. | $199.77 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $160.57 | 2024-2025 | Belbuca |
| Si-Bone, INC. | $93.18 | 2024 | |
| Pfizer INC. | $77.18 | 2020-2021 | |
| Galderma Laboratories, L.P. | $66.37 | 2021 | |
| Globus Medical, INC. | $63.23 | 2025 | Senza |
| Horizon Therapeutics Plc | $62.44 | 2020-2021 | |
| Ibsa Pharma INC. | $46.31 | 2024-2025 | Tirosint, Licart, Flector |
| Redhill Biopharma INC. | $38.37 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $37.32 | 2023-2024 | Horizant, Horizant |
| Amniox Medical, INC. | $21.75 | 2020 | |
| Boston Scientific Corporation | $19.96 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $17.38 | 2025 | Hymovis |
| Dexcom, INC. | $16.46 | 2023 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $16.06 | 2022 | |
| Scilex Pharmaceuticals INC. | $14.71 | 2021 | |
| Depuy Synthes Sales INC. | $13.95 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.14 | 2021 | |
| Hydrocision, INC. | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veena Basava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.